Prescribed Medications for Acute Treatment of Migraine Market Size, Demand Analysis 2022

The global prescribed medications for acute treatment of migraine Market size was valued at USD 2,587.9 million in 2021 and is poised to grow at a significant CAGR of 13.7% during the forecast period 2022-28. The market for prescribed medications for acute treatment of migraine is expected to offer lucrative opportunities for the market players due to the launch of novel molecules in the U.S. market. The companies have focused on novel therapeutics, an alternative to the triptan class of drugs due to the adverse effects like cardiovascular disorders, chest pressure, and others.